Physician profile
Mark D Binkley
NPI 1740418797
$817.50
in general payments reported to CMS, 2019-2025
8 companies · $173 in 2025
The $173 reported for 2025 was more than what 79% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $66.73 · 2023: $55.64 · 2024: $420 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $191.11 | 2019-2025 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Inari Medical, INC. | $182.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kerecis Limited | $149.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bsn Medical INC | $111.34 | 2024-2025 | |
| Lifenet Health | $73.09 | 2023-2025 | Theragenesis Wound Matrix |
| Stryker Corporation | $47.44 | 2021 | |
| Aroa Biosurgery Incorporated | $31.50 | 2023 | |
| Convatec INC. | $30.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Binkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.